Cellectis S.A. 13D and 13G filings for Calyxt, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2023-06-01 2:46 pm Purchase |
2023-05-31 | 13D | Calyxt, Inc. CLXT |
Cellectis S.A. | 479,264 2.900% |
0 (+0.00%) |
Filing |
| 2023-01-17 4:08 pm Unchanged |
2023-01-13 | 13D | Calyxt, Inc. CLXT |
Cellectis S.A. | 479,264 49.100% |
0 (Unchanged) |
Filing |
| 2022-11-01 4:30 pm Unchanged |
2022-10-31 | 13D | Calyxt, Inc. CLXT |
Cellectis S.A. | 479,264 49.100% |
0 (Unchanged) |
Filing |
| 2020-10-23 4:01 pm Purchase |
2020-10-16 | 13D | Calyxt, Inc. CLXT |
Cellectis S.A. | 479,264 64.700% |
25,000 (+5.50%) |
Filing |
| 2020-07-10 08:45 am Unchanged |
2020-07-06 | 13D | Calyxt, Inc. CLXT |
Cellectis S.A. | 454,264 68.700% |
0 (Unchanged) |
Filing |